May 24, 2017
Recommended Topic Related To:

Ogen

"A new study finds that women who experience frequent hot flashes in younger midlife (age 40 - 53 years) may be more likely to have poor vascular function regardless of cardiovascular disease (CVD) risk factors or estradiol levels. These findings "...

A A A

Ogen




Overdosage
Contraindications

OVERDOSE

Overdosage of estrogen may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness and fatigue, and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of OGEN therapy with institutions of appropriate symptomatic care.

CONTRAINDICATIONS

OGEN therapy should not be used in women with any of the following conditions:

  1. Undiagnosed abnormal genital bleeding.
  2. Known, suspected, or history of breast cancer.
  3. Known or suspected estrogen-dependent neoplasia.
  4. Active DVT, PE or a history of these conditions.
  5. Active arterial thromboembolic disease (for example, stroke and MI), or a history of these conditions.
  6. Known anaphylactic reaction or angioedema to OGEN tablets.
  7. Known liver dysfunction or disease.
  8. Known protein C, protein S, or anthithrombin deficiency or other known thrombophilic disorders.
  9. Known or suspected pregnancy.
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 1/9/2017

Overdosage
Contraindications

Ogen - User Reviews

Ogen User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Ogen sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.